| Application no. and date | 22713478.0 (espacenet) (Federated) (European Patent Register), 20220214 | | Patent/reg. no. and date | DK/EP 4294395, 20250326 | | Publication date | 20231227 | | Priority no. and date | US 202163149944 P, 20210216 | | EP pub. no. and date |
EP 4294395 20231227 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco CA 94080-4990, US | | Applicant ref. no. | | | Inventor | METCALFE, Ciara,
San Francisco, California 94080-4990, US,
WANG, Xiaojing,
San Francisco, California 94080-4990, US,
ZHOU, Wei,
San Francisco, California 94080-4990, US | | Representative | | | Opponent | | | IPC Class | A61K 31/422 (2006.01) , A61K 31/437 (2006.01) , A61K 31/553 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND GDC-0077 | | Int. application no. | US2022016270 | | Int. publication no. | WO2022177844 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
